InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,263.18
(
0.27%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: rkrw post# 97731

Wednesday, 06/23/2010 8:21:03 AM

Wednesday, June 23, 2010 8:21:03 AM

Post# of 252302

They don't need FDA approval to start a registration trial.



No they don't but I'd think they would want it nonetheless. If they intend on only enrolling pts who have failed 2 tki's then the trial design is fairly straight-forward. However, if the intend on enrolling pts who specifically have the T315I mutation then I'd like to see them get some clarification in advance in order to avoid some of the issues that were raised during the omapro hearing.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up